PREKLIN Research Labs
is a strategic partner for Small and Mid – Capitalization US Biopharmaceutical companies and other US organizations executing clinical studies delivering FDA quality and cost-efficient exploratory clinical trials for NCEs, 505(b)2 compounds and clinical end-point trials for generics which are executed along the US-India corridor.
